Equities recently have wobbled amid a flurry of punches but there’s still plenty of fight left in this long bull market. Read More

Once again, a famous short seller has latched onto a belief and is now relentlessly executing his strategy for cashing in on it. Read More

Multiple crises bedevil the markets. In this discussion, we interview one of our top analysts about the investment risks (and rewards) ahead. Read More

As risks at home and overseas get worse, you should boost your exposure to gold, before the rest of the investment crowd bids up its price. Read More

As bricks-and-mortar retail chains close their money-losing “big box” stores, marijuana entrepreneurs are rushing in to grab cheap space. Read More

Geopolitical risk has entered the investment equation, with potential upside for two segments in particular: defense and energy. Read More

According to a recent survey, consumers are feeling a lot less confident now than they were a year ago. Here's how you can profit from it. Read More

Investors don’t always react the way you’d expect to the news. We decipher the often manic-depressive behavior of Wall Street. Read More

The FDA approved Biogen's Alzheimer's drug. That's great news for Biogen and its shareholders, but it's also fantastic news for a competitor. Read More

Cash on corporate balance sheets in the second quarter has reached an all-time high. Here’s why that’s a powerful bullish factor. Read More